Drugmakers Criticised For Unethical Marketing Practices

Thailand's public sector pharmaceutical spending is inflated by drugmakers' aggressive marketing tactics. Last year, almost 40% of the THB158.6bn (US$4.78bn) state healthcare budget was spent on medicines, according to research presented at a recent forum. BMI believes improved regulations and better education would control state expenditure on pharmaceuticals.

To read the full article, please sign in or take a free trial.